多发性骨髓瘤骨病外科治疗专家共识(2022版)

Expert consensus on surgical treatment of multiple myeloma bone disease (2022 version)

  • 摘要: 大部分多发性骨髓瘤患者在病程中会出现骨髓瘤骨病,严重影响患者的生存质量和生存率。规范的化疗、靶向治疗和骨改良药物是治疗多发性骨髓瘤骨病的基础和最重要的部分。外科手术在多发性骨髓瘤骨病急性并发症(病理性骨折、脊柱不稳和脊髓压迫症等)的治疗中发挥着重要作用。中国抗癌协会骨肿瘤与骨转移瘤专业委员会依据循证医学方法制定了《多发性骨髓瘤骨病外科治疗专家共识》,分别对外科治疗时机、手术指征、不同部位的手术方式及综合治疗等临床问题进行总结,依据文献证据等级制定相应的推荐等级。专业委员会希望本指南能够为骨科医师的临床诊疗提供最佳的、有效的意见参考,从而使患者达到最佳的治疗效果。而本共识仅为学术性指导意见,具体实施时必须依据患者的个体医疗情况而定。

     

    Abstract: Bone diseases would be developed in most patients with multiple myeloma (MM) during the course of disease, which severely jeopardize the quality of life and survival rates of the patients. Standardized chemotherapy, targeted therapy and bone-modifying agent compose the fundamental treatments for MM, while surgical treatments play a critical role in the treatment for acute complications of bone diseases (e.g. pathological fracture, spinal instability, spinal cord compression). The Bone Tumor and Bone Metastasis Committee of Chinese Anti-Cancer Association proposes the " Expert consensus on surgical treatment of multiple myeloma bone disease". This consensus addresses several clinical problems (e.g. timing for surgical treatments, indications for operations, surgical options for lesions of different locations, and multi-modality treatments) and provides recommendations with categories of evidence and consensus. The Committee hopes that this consensus can provide the most effective references for practitioners of oncological orthopaedics in order to achieve the best outcomes for patients. But this consensus provides only academic recommendations and should be adapted to individualized treatments during clinical practice.

     

/

返回文章
返回